Story perspectives

Revolutionary Screening Tool Saves Newborn's Vision in England

10/17/2025

Summary

Story summary

Freddie Underhay, the patient in England, was diagnosed with hereditary retinoblastoma shortly after birth.
The Generation Study tests a new screening tool that screens 100,000 newborns for genetic conditions using whole genome sequencing.
Freddie's early diagnosis allowed laser therapy and chemotherapy, which doctors hope will save his vision.
The Generation Study aims to make genomic sequencing routine for all newborns in the UK, improving diagnosis and treatment for many children.

1 of 1

Story summary

Freddie Underhay, the patient in England, was diagnosed with hereditary retinoblastoma shortly after birth.
The Generation Study tests a new screening tool that screens 100,000 newborns for genetic conditions using whole genome sequencing.
Freddie's early diagnosis allowed laser therapy and chemotherapy, which doctors hope will save his vision.
The Generation Study aims to make genomic sequencing routine for all newborns in the UK, improving diagnosis and treatment for many children.